NextCure, Inc. Balance Sheet
NXTC|3 years of annual SEC 10-K data (FY2019-FY2021)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$242M
FY2021
Cash
$12M
Cash and equivalents
Total Debt
N/A
FY2021
Shareholder Equity
$294M
FY2021
NextCure, Inc. had $242M in total assets and $294M in shareholders' equity as of FY2021.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2021 | FY2020 | FY2019 |
|---|---|---|---|
| Cash & Equivalents | $12.3M | $32.8M | $34.1M |
| Current Assets | $227.8M | $288.0M | $340.0M |
| PP&E (Net) | $14.0M | $15.8M | $12.1M |
| Total Assets | $242.4M | $306.6M | $356.2M |
| Current Liabilities | $6.6M | $10.3M | $15.0M |
| Total Debt | - | $1.8M | $5.0M |
| Shareholders' Equity | $293.7M | $321.5M | -$46.9M |